Savara Inc. (NASDAQ:SVRA – Get Free Report) shares hit a new 52-week low during trading on Friday. The stock traded as low as $4.00 and last traded at $4.4320, with a volume of 4,158,457 shares. The stock had previously closed at $5.21.
Analysts Set New Price Targets
Several equities analysts recently weighed in on SVRA shares. Royal Bank Of Canada set a $10.00 price target on Savara in a report on Wednesday, October 7th. Wall Street Zen downgraded Savara from a “hold” rating to a “sell” rating in a research report on Sunday, October 4th. Citigroup reissued a “market outperform” rating on shares of Savara in a research note on Wednesday, October 7th. Weiss Ratings reissued a “sell (d-)” rating on shares of Savara in a research report on Thursday, October 15th. Finally, JPMorgan Chase & Co. started coverage on Savara in a research report on Wednesday, October 7th. They set an “overweight” rating and a $12.00 target price on the stock. Six investment analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Savara has an average rating of “Moderate Buy” and an average target price of $10.29.
Check Out Our Latest Stock Analysis on SVRA
Savara Trading Down 17.2%
The company has a debt-to-equity ratio of 0.28, a current ratio of 8.55 and a quick ratio of 8.55. The stock has a market cap of $951.98 million, a price-to-earnings ratio of -7.17 and a beta of 0.32. The company’s fifty day moving average price is $4.88 and its 200-day moving average price is $5.32.
Savara (NASDAQ:SVRA – Get Free Report) last released its earnings results on Monday, November 9th. The company reported ($0.17) EPS for the quarter, topping analysts’ consensus estimates of ($0.18) by $0.01. On average, research analysts expect that Savara Inc. will post -0.68 EPS for the current fiscal year.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Quarry LP increased its position in shares of Savara by 6,524.4% in the 3rd quarter. Quarry LP now owns 11,924 shares of the company’s stock valued at $62,000 after acquiring an additional 11,744 shares during the period. Jump Financial LLC purchased a new position in Savara in the 3rd quarter worth $720,000. Marshall Wace LLP lifted its position in Savara by 2.1% during the 3rd quarter. Marshall Wace LLP now owns 6,386,775 shares of the company’s stock worth $32,956,000 after acquiring an additional 129,786 shares during the period. Nantahala Capital Management LLC lifted its position in Savara by 2.3% during the 3rd quarter. Nantahala Capital Management LLC now owns 7,137,159 shares of the company’s stock worth $36,828,000 after acquiring an additional 160,349 shares during the period. Finally, Nan Fung Trinity HK Ltd. lifted its position in Savara by 1,088.3% during the 3rd quarter. Nan Fung Trinity HK Ltd. now owns 1,842,350 shares of the company’s stock worth $9,507,000 after acquiring an additional 1,687,310 shares during the period. Hedge funds and other institutional investors own 87.93% of the company’s stock.
About Savara
Savara is a biopharmaceutical company focused on developing treatments for serious and rare respiratory diseases. The company is based in the United States and concentrates its research and development efforts on conditions with limited treatment options. Savara’s lead product candidate is molgramostim, an inhaled form of granulocyte-macrophage colony-stimulating factor (GM-CSF). It has been developed as a potential treatment for autoimmune pulmonary alveolar proteinosis, a rare lung disease in which the buildup of material in the air sacs can impair breathing.
Featured Stories
- Five stocks we like better than Savara
- Apple’s Rare Samsung Memory Plan Could Solve One Problem and Create Another
- Palo Alto Networks’ Q1 Beat Gives Its Stock Rally Another Reason to Run
- Airfares Are Up, Flights Are Tight: 3 Airline Stocks Facing a Winter Test
- Hard Drives Were Left for Dead, But Seagate and Western Digital Are Soaring
Receive News & Ratings for Savara Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Savara and related companies with MarketBeat.com's FREE daily email newsletter.
